Turbine (Drug Discovery)

London, United Kingdom · Founded 2015 · Privately Held (backing)

Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies. Turbine (Drug Discovery) is based in London, United Kingdom and was founded in 2015. Its last reported valuation was $90.2 million in Nov 2025. It has raised $64.4 million.

Last reported valuation
$90.2M
Oct 2026
Priced at
—
Total raised
$64.4M
Last round
—

Who backs Turbine (Drug Discovery)?

24 investors
InvestorType
AccelVenture capital
AWS StartupsOther
Mercia VenturesVenture capital
MassMutual VenturesOther
Crane Venture PartnersVenture capital
Accenture VenturesVenture capital
XTX Ventures—
MSD Global Health Innovation FundVenture capital
Mercia Asset ManagementVenture capital
Esther DysonOther
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Turbine (Drug Discovery) investors

24 investors are on record for Turbine (Drug Discovery), including Accel, AWS Startups, Mercia Ventures and MassMutual Ventures. By type, the record holds 6 venture capital firms.

Free account
More of Turbine (Drug Discovery) with a free account
  • ·The complete investor list: 24 names
  • ·Watch Turbine (Drug Discovery): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Turbine (Drug Discovery). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View